COMPAMED 2022: Dymax to present pioneering light-curing technology for medical devices

Dymax, a leading manufacturer of rapid curing materials and equipment, will exhibit at COMPAMED, which will be held in conjunction with MEDICA in Düsseldorf, Germany, from November 14 to 17. In Hall 8b, Booth L01, Dymax will present its latest developments for the medical device industry.

The focus will be on the innovative light-curing adhesives of the 2000-MW series, which have been formulated without commonly used skin-irritating ingredients, and thus meet the special requirements for medical wearables. The development process eliminated the use of IBOA, a known skin sensitizer. All products in this adhesive range meet the requirements of ISO standard 10993-10/-23 for sensitization and skin irritation and ISO standard 10993-5 for cytotoxicity. Typical applications include medical wearables and devices worn close to the skin, such as blood glucose meters, large-volume injectors, patient monitoring devices, and pain management devices.

In addition, MD®1040-M has been added to the medical adhesive product line. It is particularly suitable as an adhesive or encapsulation material for medical devices and surgical instruments that require frequent sterilization. Its excellent resistance to the aggressive sterilization methods used in medical technology and its excellent adhesion to a wide range of substrates make it a differentiating and unique offering to the market, helping solve some of the hardest design challenges As a result, this light-curable adhesive is ideal for surgical instruments and medical devices that undergo numerous autoclave or hydrogen peroxide-plasma sterilization cycles, but it can also be used as an encapsulation material to protect critical sensors and electronic components where moisture ingress must be prevented.

Of particular interest to medical device manufacturers are also the latest UV/LED or UV broad-spectrum curing devices, including the powerful Dymax BlueWave® QX4 2.0 LED spot-curing system and the newly developed Dymax BlueWave® FX-1250 high-intensity LED flood-curing system.

Dymax application engineering experts will be on hand to answer your questions about light-curing materials and curing systems, discuss customer applications in detail, and offer demonstrations of key products and technologies.

Email us to find out how to get a FREE visitor day ticket, or visit the MEDICA/Compamed websites to learn about our latest products now.

Über die DYMAX Europe GmbH

Dymax is specialized in advanced light-curing materials and leading supplier of systems solutions to increase efficiency in production processes. The Wiesbaden, Germany, based company not only develops oligomers, adhesives, coatings and light-curing systems for applications, but also assists manufacturers in developing individual process solutions. Major markets to be served include medical device, electronics, aerospace and automotive.

Dymax Corporation is headquartered in Torrington, Connecticut, USA. Alongside Germany, further subsidiaries are located in Ireland, Hong Kong, Singapore and Korea. Dymax employs more than 450 people worldwide.

Firmenkontakt und Herausgeber der Meldung:

DYMAX Europe GmbH
Kasteler Straße 45
65203 Wiesbaden
Telefon: +49 (611) 962-7900
Telefax: +49 (611) 962-9440
https://de.dymax.com/

Ansprechpartner:
Dr. Lydia Duhm-McCann
Product Management EMEA
E-Mail: lduhmmccann@dymax.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel